Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Nuclear Medicine and Molecular Imaging
Published in: Nuclear Medicine and Molecular Imaging 2/2018

01-04-2018 | Case Report

Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT

Authors: N. T. K. Thanseer, Sanjay Kumar Bhadada, Ashwani Sood, Ashwin Singh Parihar, Divya Dahiya, Priyanka Singh, Rajender Kumar Basher, Ashim Das, Bhagwant R. Mittal

Published in: Nuclear Medicine and Molecular Imaging | Issue 2/2018

Login to get access

Abstract

18F-Fluorocholine (FCH) PET/CT is evolving as a functional imaging modality for the preoperative imaging of abnormal parathyroid tissue(s) helping to localize eutopic and ectopic parathyroid tissue and limit the extent of surgery. FCH PET/CT may show incidental uptake in various thyroid lesions necessitating further evaluation, whereas the role of 18F-fluorodeoxyglucose (FDG) PET/CT in the detection of incidental thyroid nodules is well documented. The case of a middle-aged woman with dual pathology of parathyroid adenoma and papillary thyroid cancer detected on FCH and FDG PET/CT is presented.
Literature
1.
Lezaic L, Rep S, Sever MJ, Kocjan T, Hocevar M, Fettich J. 18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41:2083–9.CrossRefPubMed
2.
Eccles A, Challapalli A, Khan S, Barwick T, Mangar S. Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT. Clin Nucl Med. 2013;38:755–7.CrossRefPubMed
3.
Aziz AL, Courbon F, Dierickx LO, Pascal P, Zerdoud S. Oncocytic adenoma of thyroid incidentally detected by 18F-fluorocholine PET/CT. J Nucl Med Technol. 2015;43:133–4.CrossRefPubMed
4.
Wu HB, Wang QS, Wang MF, Li HS. Utility of 11C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma. Clin Nucl Med. 2011;36:91–5.CrossRefPubMed
5.
Paone G, Treglia G, Bongiovanni M, Ruberto T, Ceriani L, Giovanella L. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer. Rev Esp Med Nucl Imagen Mol. 2013;32:340–1.PubMed
6.
Piccardo A, Massollo M, Bandelloni R, Arlandini A, Foppiani L. Lymph node metastasis from tall-cell thyroid cancer negative on 18F-FDG PET/CT and detected by 18F-choline PET/CT. Clin Nucl Med. 2015;40:e417–9.CrossRefPubMed
7.
Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography; a systematic review. Thyroid. 2012;22:918–25.CrossRefPubMed
8.
Hindie E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Urena P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–16.CrossRefPubMed
9.
Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF. The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 2011;117:4582–94.CrossRefPubMed
10.
Savelli G, Basile P, Muni A, Bna C, Pizzocaro C, Pagani R. Focal thyroid uptake during 18F-choline PET/CT: a case report. Case Rep Clin Med. 2015;4:345–8.CrossRef
Metadata
Title
Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT
Authors
N. T. K. Thanseer
Sanjay Kumar Bhadada
Ashwani Sood
Ashwin Singh Parihar
Divya Dahiya
Priyanka Singh
Rajender Kumar Basher
Ashim Das
Bhagwant R. Mittal
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 2/2018
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-017-0488-3

Other articles of this Issue 2/2018

Nuclear Medicine and Molecular Imaging 2/2018 Go to the issue

Original Article

123I–Labeled oxLDL Is Widely Distributed Throughout the Whole Body in Mice

Review

Radiomics as a Quantitative Imaging Biomarker: Practical Considerations and the Current Standpoint in Neuro-oncologic Studies

Review

Deep Learning in Nuclear Medicine and Molecular Imaging: Current Perspectives and Future Directions

Interesting Image

Follicular Lymphoma mimicking Metastatic Nodes on the F-18 FDG PET/CT and MRI for Staging of Endometrial Cancer

Interesting Image

Focal Increased Tc-99m MDP Uptake in the Nutrient Foramen of the Femoral Diaphysis on Bone SPECT/CT

Editorial

Message from the Editor-in-Chief: Theranostic Imaging in 2018